Pharmacoeconomic Analysis of Bemiparin and Enoxaparin as Prophylaxis for Venous Thromboembolism in Total Knee Replacement Surgery
- 1 January 2004
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (13) , 885-894
- https://doi.org/10.2165/00019053-200422130-00006
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Review of bemiparin sodium – a new second-generation low molecular weight heparinand its applications in venous thromboembolismExpert Opinion on Pharmacotherapy, 2003
- Enoxaparin versus tinzaparin in non-ST–segment elevation acute coronary syndromes: the EVET trialAmerican Heart Journal, 2003
- Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trialJournal of Thrombosis and Haemostasis, 2003
- Low molecular weight heparins: are they interchangeable? NoJournal of Thrombosis and Haemostasis, 2003
- Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.2001
- Prevention of Venous ThromboembolismChest, 2001
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999
- FROM THE FDAAnesthesiology, 1998
- Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working GroupPublished by American Medical Association (AMA) ,1997
- From the Food and Drug AdministrationPublished by American Medical Association (AMA) ,1993